Panel Sessions Search A Fireside Chat with Michael Devoy, CMO of Bayer AG Clone 2 (2022) A Fireside Chat with Michael Devoy, CMO of Bayer AG (2024) Investment Perspective – Daniel Couto (2024) Panel 1: Tyrosine Kinase Inhibitors & Other Novel Mechanisms for the Treatment of Neovascular AMD: Is There Unmet Need? (2024) Panel 2: The Impact of Extended Duration with Injections on Novel Drug Delivery Approaches for Posterior Segment Diseases (2023)
